Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): Effects on size, physical stability and particle matrix structure

被引:256
作者
Kovacevic, A. [3 ]
Savic, S. [3 ]
Vuleta, G. [3 ]
Mueller, R. H. [4 ]
Keck, C. M. [1 ,2 ]
机构
[1] Univ Appl Sci Kaiserslautern, Dept Appl Logist & Polymer Sci, Pirmasens, Germany
[2] Univ Putra Malaysia, Inst Biosci IBS, Serdang, Malaysia
[3] Univ Belgrade, Dept Pharmaceut Technol & Cosmetol, Fac Pharm, Belgrade 11221, Serbia
[4] Free Univ Berlin, Dept Pharmaceut Biopharmaceut & NutriCosmet, D-12169 Berlin, Germany
关键词
Polyhydroxy surfactants; Solid lipid nanoparticles; SLN; Nanostructured lipid carriers; NLC; Physical stability; Crystallinity; CONTROLLED DRUG-DELIVERY; CARRIERS NLC; SAFETY ASSESSMENT; DERMAL PRODUCTS; FINAL REPORT; SPECTROSCOPY; CRYSTALLIZATION; CYCLOSPORINE; PHASE; STATE;
D O I
10.1016/j.ijpharm.2010.12.036
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The two polyhydroxy surfactants polyglycerol 6-distearate (Plurol (R) Stearique WL1009 - (PS)) and caprylyl/capryl glucoside (Plantacare (R) 810 - (PL)) are a class of PEG-free stabilizers, made from renewable resources. They were investigated for stabilization of aqueous solid lipid nanoparticle (SIN) and nanostructured lipid carrier (NLC) dispersions. Production was performed by high pressure homogenization, analysis by photon correlation spectroscopy (PCS), laser diffraction (LD), zeta potential measurements and differential scanning calorimetry (DSC). Particles were made from Cutina CP as solid lipid only (SIN) and its blends with Miglyol 812 (NLC, the blends containing increasing amounts of oil from 20% to 60%). The obtained particle sizes were identical for both surfactants, about 200 nm with polydispersity indices below 0.20 (PCS), and unimodal size distribution (ID). All dispersions with both surfactants were physically stable for 3 months at room temperature, but Plantacare (PL) showing a superior stability. The melting behaviour and crystallinity of bulk lipids/lipid blends were compared to the nanoparticles. Both were lower for the nanoparticles. The crystallinity of dispersions stabilized with PS was higher, the zeta potential decreased with storage time associated with this higher crystallinity, and leading to a few, but negligible larger particles. The lower crystallinity particles stabilized with PL remained unchanged in zeta potential (about -50 mV) and in size. These data show that surfactants have a distinct influence on the particle matrix struture (and related stability and drug loading), to which too little attention was given by now. Despite being from the same surfactant class, the differences on the structure are pronounced. They are attributed to the hydrophobic-lipophilic tail structure with one-point anchoring in the interface (PL), and the loop conformation of PS with two hydrophobic anchor points, i.e. their molecular structure and its interaction with the matrix surface and matrix bulk. Analysis of the effects of the surfactants on the particle matrix structure could potentially be used to further optimization of stability, drug loading and may be drug release. (c) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:163 / 172
页数:10
相关论文
共 47 条
[1]   Influence of spin probe structure on its distribution in SLN dispersions [J].
Ahlin, P ;
Kristl, J ;
Sentjurc, M ;
Strancar, J ;
Pecar, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 196 (02) :241-244
[2]   Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid:: Characterization [J].
Attama, A. A. ;
Schicke, B. C. ;
Paepenmueller, T. ;
Mueller-Goymann, C. C. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2007, 67 (01) :48-57
[3]   Solid lipid nanoparticles for targeted brain drug delivery [J].
Blasi, Paolo ;
Glovagnoli, Stefano ;
Schoubben, Aurelie ;
Ricci, Maurizio ;
Rossi, Carlo .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (06) :454-477
[4]   Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy [J].
Borgia, SL ;
Regehly, M ;
Sivaramakrishnan, R ;
Mehnert, W ;
Korting, HC ;
Danker, K ;
Röder, B ;
Kramer, KD ;
Schäfer-Korting, M .
JOURNAL OF CONTROLLED RELEASE, 2005, 110 (01) :151-163
[5]  
BORGIA SL, 2007, EUR J PHARM BIOPHARM
[6]   Influence of emulsifiers on the crystallization of solid lipid nanoparticles [J].
Bunjes, H ;
Koch, MHJ ;
Westesen, K .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (07) :1509-1520
[7]  
Bunjes H, 2002, PROG COLL POL SCI S, V121, P7
[8]   Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase [J].
Freitas, C ;
Müller, RH .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1999, 47 (02) :125-132
[9]  
Garti N., 2001, Crystallization Processes in Fats and Lipid Systems, P211
[10]  
Johnson W, 2001, INT J TOXICOL, V20, P13